Eli Lilly weight loss pill shows promise, but not as strong as injectables

Eli Lilly’s experimental oral weight loss pill helped patients lose about 12 percent of their body weight on average in a late-stage trial, the company said Thursday, positive results but still less than its injectable competitors.  Lilly’s stock was down more than 14 percent on the day after the results were announced.  After 72 weeks,…